GSA Capital Partners’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-99,394
Closed -$294K 2051
2025
Q1
$294K Sell
99,394
-9,129
-8% -$27K 0.03% 1172
2024
Q4
$331K Buy
108,523
+59,029
+119% +$180K 0.02% 1152
2024
Q3
$126K Sell
49,494
-140,257
-74% -$357K 0.01% 1470
2024
Q2
$619K Buy
189,751
+2,166
+1% +$7.07K 0.04% 829
2024
Q1
$994K Sell
187,585
-74,752
-28% -$396K 0.08% 441
2023
Q4
$1.14M Sell
262,337
-17,292
-6% -$74.9K 0.1% 332
2023
Q3
$735K Buy
279,629
+164,931
+144% +$434K 0.06% 565
2023
Q2
$405K Buy
+114,698
New +$405K 0.04% 870
2023
Q1
Sell
-72,940
Closed -$309K 1824
2022
Q4
$309K Sell
72,940
-67,381
-48% -$285K 0.04% 914
2022
Q3
$333K Buy
140,321
+71,572
+104% +$170K 0.04% 857
2022
Q2
$196K Sell
68,749
-70,194
-51% -$200K 0.03% 1076
2022
Q1
$400K Buy
+138,943
New +$400K 0.05% 700
2021
Q4
Sell
-86,040
Closed -$603K 1693
2021
Q3
$603K Buy
86,040
+71,155
+478% +$499K 0.06% 588
2021
Q2
$137K Buy
+14,885
New +$137K 0.02% 1226
2020
Q1
Sell
-83,686
Closed -$732K 1425
2019
Q4
$732K Buy
83,686
+59,186
+242% +$518K 0.09% 392
2019
Q3
$264K Sell
24,500
-5,218
-18% -$56.2K 0.04% 1012
2019
Q2
$378K Buy
29,718
+23,283
+362% +$296K 0.04% 843
2019
Q1
$250K Buy
+6,435
New +$250K 0.03% 1109
2015
Q3
Sell
-34,625
Closed -$4.04M 1964
2015
Q2
$4.04M Buy
34,625
+23,511
+212% +$2.74M 0.16% 86
2015
Q1
$2.62M Buy
11,114
+6,521
+142% +$1.54M 0.1% 209
2014
Q4
$869K Sell
4,593
-3,506
-43% -$663K 0.06% 563
2014
Q3
$1.93M Buy
+8,099
New +$1.93M 0.1% 204
2014
Q2
Sell
-15,698
Closed -$1.64M 1924
2014
Q1
$1.64M Buy
+15,698
New +$1.64M 0.12% 168
2013
Q4
Sell
-11,500
Closed -$617K 1737
2013
Q3
$617K Buy
11,500
+2,900
+34% +$156K 0.05% 640
2013
Q2
$382K Buy
+8,600
New +$382K 0.05% 725